Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: Tenpoint who wrote (354)	12/27/1997 8:42:00 AM
From: flickerful	Read Replies (1) \| Respond to of 756

<< And who would ever want to take the risk of buying this company with so much competition.>> i ask myself that question everyday, especially when trading is vigorous, as it has been. now, i am not so sure how vigorous it will be .however, nothing surprises me from this crew: they may well have in place another seven (7) or eight (8) releases crammed with non-core divestments, or out of the blue generics... i am *not* , certainly , fond of frosty and the gang, but somehow i think this is not the end of near term prospects, as we know it. abysmal numbers may not prevail as far-fetched as that may now appear...at least the ta supports this contention, and i feel paxene was long ago included in those factors, whether i like it or not. randy